Created by potrace 1.16, written by Peter Selinger 2001-2019beatandraise.com
Latest Financials

Filings:

CategoryDateSearch FilingsInstitutional HoldersbetaEarnings TranscriptsbetaGlobal Search

SEC Edgar

Denali Therapeutics Inc.

SIC 2836 · Biological Products, (No Diagnostic Substances)
NotesSupport
aboutterms
$DNLI

Denali Therapeutics Inc.

CIK:0001714899|SEC Filings

MATERIAL CONTRACTS

EX-10.1
exhibit101assetpurchaseagr.htm
2026-08-06T00:00:00Z
EX-10.2
exhibit102denali_royaltyph.htm
2026-05-07T00:00:00Z
EX-10.1
exhibit101outsidedirectorc.htm
2026-05-07T00:00:00Z
EX-10.1
affiliateregistrationright.htm
2025-06-03T00:00:00Z
EX-10.3
amendedoutsidedirectorcomp.htm
2025-05-06T00:00:00Z
EX-10.1
genzymenoticeofpartialterm.htm
2025-05-06T00:00:00Z
EX-10.2
takedanoticeofpartialtermi.htm
2025-05-06T00:00:00Z
EX-10.1
denali-biogensideletter.htm
2024-08-01T00:00:00Z
EX-10.35
exhibit1035denaliinsiderpo.htm
2024-02-28T00:00:00Z
EX-10.34
exhibit1034compensationrec.htm
2024-02-28T00:00:00Z
EX-10.2
exhibit102nominatingagreem.htm
2024-02-27T00:00:00Z
EX-10.1
a101pipespa.htm
2024-02-27T00:00:00Z
EX-10.1
amendmenttodefinitivelrrk2.htm
2023-11-07T00:00:00Z
EX-10.129
amendmentno9todevelopmenta.htm
2023-02-27T00:00:00Z
EX-10.128
amendmentno8todevelopmenta.htm
2023-02-27T00:00:00Z
EX-10.127
amendmentno7todevelopmenta.htm
2023-02-27T00:00:00Z
EX-10.15
exhibit1015amendedandresta.htm
2022-02-28T00:00:00Z
EX-10.1
denalif-starsideletter.htm
2021-08-04T00:00:00Z
EX-10.1
ex101amendandrestoutsidedi.htm
2021-05-05T00:00:00Z
EX-10.12.4
ex10124amendmentno5todmsa.htm
2021-02-26T00:00:00Z